24 | Dr Natasha Davendralingam Co-CEO, Anubix, Consultant Radiologist Natasha is a Consultant Radiologist, Co-Founder and CEO of Anubix, and an NHS Clinical Entrepreneur Programme Fellow. Through Anubix, Natasha is pioneering a new model of post-mortem imaging and death investigation, using post-mortem CT to offer faster, less invasive and more dignified alternatives to traditional autopsy. Her work spans radiology, pathology, coronial law, medico-legal practice, healthcare innovation, AI, ethics and family-centred death care. Anubix has developed award-winning PMCT services across NHS, local authority and coronial settings, improving access to modern death investigation pathways and helping reduce delays for bereaved families. Natasha has also led the creation of Anubix Academy, the world’s first virtual post-mortem imaging learning platform, alongside practical training, international education initiatives, governance frameworks and the After Life Imaging Clinic, a family-facing service designed to help loved ones understand post-mortem imaging findings with compassion and clarity. www.anubix.co.uk LinkedIn: /company/anubixradiology Instagram: @anubixafterlife Dr Frances Duffy Founder and CEO, 6D-Dementia Ltd. Dr Frances Duffy, a Consultant Clinical Psychologist, has over 15 years of experience in dementia care. As an NHS Clinical Entrepreneur, she founded 6D-Dementia Ltd., with support from Techstart and Innovate UK. 6D is transforming dementia care with the innovative online training platform designed for caregivers, care homes, domiciliary care providers, local authorities, the voluntary sector, and NHS organisations. 6D delivers evidence-based, role-specific training that empowers caregivers and healthcare professionals to provide high-quality, person-centred dementia care. Interest in 6D is growing rapidly, with NHS trusts and other organisations recognising its ability to address urgent workforce needs, reduce caregiver stress and burnout, staff turnover and staff absence. Quality training delivers measurable cost savings by reducing breakdown in living arrangements, decreasing unnecessary hospital admissions and reducing the need for psychotropic medications with significant side effects. It also enables people with dementia to live independently for longer and improves quality of life. LinkedIn: /in/frances-duffy-6d X: @duffy_frances www.6ddementia.com
RkJQdWJsaXNoZXIy MTA4ODM=